10X Genomics

Forecast & Rating19 analysts currently cover 10X Genomics, with about 36.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $62.13, about 31.0% downside from the current price of $90.04. Price targets range from $40.00 to $90.00 — a wide spread, showing clear disagreement over just how much 10X Genomics can rise. Historically, about 49.4% of past price targets were eventually met, which adds credibility. For you, this means most institutions are cautious on 10X Genomics's outlook. Data as of Sep 29, 2026; for reference only and not investment advice.